Best Antibiotics for Skin Infections Caused by Staphylococcus aureus, Including MRSA
For skin infections caused by Staphylococcus aureus, including MRSA, clindamycin is the preferred first-line oral antibiotic due to its effectiveness against both MRSA and β-hemolytic streptococci, with trimethoprim-sulfamethoxazole, tetracyclines, and linezolid as alternative options based on infection severity and patient factors. 1
Initial Management Approach
- Incision and drainage is the primary treatment for cutaneous abscesses, and may be adequate alone for simple abscesses without antibiotics 2
- Antibiotic therapy is recommended when abscesses are associated with:
- Severe or extensive disease involving multiple sites 2
- Rapid progression with associated cellulitis 2
- Signs and symptoms of systemic illness 2
- Associated comorbidities or immunosuppression 2
- Extremes of age 2
- Abscess in difficult-to-drain areas (face, hand, genitalia) 2
- Associated septic phlebitis 2
- Lack of response to incision and drainage alone 2
Recommended Oral Antibiotics for Outpatient Treatment
First-Line Options:
Clindamycin (300-450 mg three times daily for adults):
Trimethoprim-sulfamethoxazole (TMP-SMX) (1-2 double-strength tablets twice daily):
Tetracyclines (doxycycline 100 mg twice daily or minocycline 100 mg twice daily):
Second-Line Option:
- Linezolid (600 mg twice daily):
Treatment for Hospitalized Patients with Complicated Infections
For patients requiring hospitalization with complicated skin infections (deeper soft-tissue infections, surgical/traumatic wound infection, major abscesses):
- Vancomycin (IV): First-line parenteral therapy for MRSA 2
- Linezolid (600 mg IV/PO twice daily): Equivalent efficacy to vancomycin 2
- Daptomycin (4 mg/kg IV once daily): Effective for MRSA skin infections 2
- Telavancin (10 mg/kg IV once daily): Alternative for complicated infections 2
Duration of Therapy
- 5-10 days for uncomplicated skin infections, individualized based on clinical response 2, 1
- 7-14 days for complicated skin infections 2, 1
Special Populations
Pediatric Patients:
- Mupirocin 2% topical ointment for minor skin infections 2
- Clindamycin (10-13 mg/kg/dose IV every 6-8 hours or 10-20 mg/kg/day PO in 3 divided doses) 2
- Vancomycin for hospitalized children with complicated infections 2
- Linezolid (10 mg/kg/dose every 8 hours for children <12 years; 600 mg twice daily for children >12 years) 2
- Avoid tetracyclines in children under 8 years of age 2
Common Pitfalls to Avoid
- Do not use rifampin as a single agent or as adjunctive therapy for MRSA skin infections 2
- TMP-SMX should not be used as a single agent for non-purulent cellulitis due to poor streptococcal coverage 2
- For patients with purulent drainage, always obtain cultures to guide therapy 2
- Consider local resistance patterns when selecting empiric therapy 1
- Do not rely on vancomycin for outpatient oral therapy as it has poor oral bioavailability 1